Rani Therapeutics Holdings share price logo

Rani Therapeutics Holdings

NASDAQ: RANI

$0.76

-0.07

(-7.97%)

as on

Rani Therapeutics Holdings Stock Performance

as on September 17, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $0.78
    $0.84
    downward going graph

    -3.17%

    Downside

    11.11%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.45
    $3.87
    downward going graph

    41.10%

    Downside

    411.90%

    Upside

    downward going graph

Rani Therapeutics Holdings share price movements today

Previous Close
$0.82
Open
$0.84
Volume
766.2K
Market Cap
$115.4M
Day's Low - High
$0.78 - $0.84
52 Week Low - High
$0.45 - $3.87

Rani Therapeutics Holdings Historical Returns

1 Month Return
-5.01 %
3 Month Return
-1.2 %
1 Year Return
+ 60.71 %
3 Year Return
-72.41 %
5 Year Return
-95.97 %

Rani Therapeutics Holdings Stock Fundamentals & Key Indicators

Check Rani Therapeutics Holdings market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$115.4M

EPS (TTM)

-0.1733

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-32.2M

Revenue (TTM)

4.9M

Profit Margin

0.00%

Return On Equity TTM

-172.15%

Rani Therapeutics Holdings vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Rani Therapeutics Holdings with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$115.4M-95.97%NA0.00%NA
BUY$43.9B527.35%NA0.00%NA
BUY$130.4B172.58%29.7186.04%NA
BUY$57.4B-66.14%-18.02-12.57%NA
BUY$81.7B18.83%18.4884.86%47.8%

Stock Returns calculator for Rani Therapeutics Holdings Stock including INR - Dollar returns

The Rani Therapeutics Holdings stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Rani Therapeutics Holdings investment value today

Current value as on today

₹1,75,247

Returns

₹75,247

(+75.25%)

Returns from Rani Therapeutics Holdings Stock

₹60,714 (+60.71%)

Dollar Impact

₹14,533 (+14.53%)

Analyst Recommendation on Rani Therapeutics Holdings Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Rani Therapeutics Holdings. Average target price of $7.2

Rani Therapeutics Holdings Share Price Target

Get share price movements and forecasts by analysts on Rani Therapeutics Holdings.

What analysts predicted

89.5%UPSIDE

Target Price

$7.2

Current Price

$0.756

Analyzed by

4 Analysts

Target

$7.20

Rani Therapeutics Holdings target price $7.2, a slight upside of 89.5% compared to current price of $0.756. According to 4 analysts rating.

Indian Investors' Interest in Rani Therapeutics Holdings Stock

Search interest for Rani Therapeutics Holdings Stock has decreased by -4% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-4% versus previous 30 day period

Rani Therapeutics Holdings Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
1
0
-
-
1
1
1
Gross Profit
0
0
0
1
0
0
0
1
1
1
Operating Income
-14
-12
-11
-14
-12
-10
-7
-8
-8
-8
EBITDA
-13
-11
-11
-14
-11
-10
-6
-8
-7
-8
Interest Expense
1
1
1
1
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-14
-13
-12
-15
-12
-11
-7
-9
-8
-8
Income Tax Expense
-7
-6
-
-
-
-
-
-
-
-
Net Income
-7
-6
-6
-8
-7
-6
-5
-10
-7
-7
Net Profit Margin
0.00%
0.00%
0.00%
-870.33%
-4223.26%
0.00%
0.00%
-705.34%
-411.77%
-432.73%

Rani Therapeutics Holdings Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
2
-
-
1
1
Gross Profit
0
0
2
-1
0
1
0
Operating Income
-27
-16
-51
-63
-66
-53
-38
EBITDA
-26
-15
-52
-61
-61
-50
-37
Interest Expense
0
0
0
1
5
5
2
Depreciation
0
0
0
0
0
1
0
Income Before Tax
-26
-16
-53
-63
-67
-30
-40
Income Tax Expense
0
0
0
0
-33
26
-
Net Income
-26
-16
-8
-30
-33
-30
-29
Net Profit Margin
-2716.75%
-3615.37%
-306.62%
0.00%
0.00%
-2920.04%
-1817.09%

Rani Therapeutics Holdings Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-6
-12
-15
-12
-11
-7
-9
-8
-8
Operating Cash Flow
-9
-8
-8
-8
-5
-5
0
-6
-9
Investing Cash Flow
6
0
2
18
5
0
-30
-2
-14
Financing Cash Flow
0
7
5
-3
0
-1
44
0
18
Change in Cash
-2
0
0
6
0
-6
14
-8
-4

Rani Therapeutics Holdings Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-16
-8
-63
-33
-56
-29
Operating Cash Flow
-14
-32
-46
-51
-35
-18
Investing Cash Flow
-1
0
-72
29
19
-7
Financing Cash Flow
72
77
29
0
13
40
Change in Cash
56
44
-89
-21
-2
14

Mutual Funds that own Rani Therapeutics Holdings Stock

Check out the Mutual Funds with significant holdings in Rani Therapeutics Holdings.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.934309%
4541175
Fidelity Concord Street Trust
0.60805%
701842
Bridgeway Funds, Inc.
0.099198%
114500
VANGUARD VALLEY FORGE FUNDS
0.043223%
49891
VANGUARD INSTITUTIONAL INDEX FUNDS
0.027291%
31501

Global Institutional Holdings in Rani Therapeutics Holdings

Funds
Holdings
Peter Kolchinsky
7.36%
Vanguard
3.88%
iShares
0.13%
Andrew J.M. Spokes
0.02%
Invesco
0.01%

Insights on Rani Therapeutics Holdings

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 482.5% return, outperforming this stock by 421.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 27.1% return, outperforming this stock by 99.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, RANI stock has moved down by -8.0%

About Rani Therapeutics Holdings

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat rheumatoid arthritis; RT-116 which is in discovery stage for the treatment of obesity; RT-117 for rare diseases; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The company has a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity; Chugai Pharmaceutical Co., Ltd. to commercialize the Chugai Product combining Chugai's Compound, which is in development for hemophilia, and the RaniPill HC oral delivery device for use in humans; and has a research and development collaboration with PegBio Co., Ltd. to expand obesity pipeline across multiple novel candidates. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.
OrganisationRani Therapeutics Holdings
Headquarters2051 Ringwood Avenue, San Jose, CA, United States, 95131
IndustryBiotechnology
CEOMr. Talat Imran
E-voting on sharesClick here to vote

Key Management of Rani Therapeutics Holdings

Name

Title

Ms. Arvinder Dhalla

Vice President of Clinical Development

Mr. Alireza Javadi Ph.D.

Chief Technical Officer

Dr. Mir Hashim

Chief Scientific Officer

Mr. Jesper Hoeiland M.Sc.

Head of Strategy

Mr. Nicholas Maestas

Chief Financial Officer

Ms. Bella Vazquez

Senior Vice President of People & Administrative Services

Mr. Mir A. Imran

Executive Chairman

Mr. Talat Imran

CEO & Director

Ms. Kate McKinley M.B.A.

Chief Business Officer

FAQs

What is Rani Therapeutics Holdings share price today?

Rani Therapeutics Holdings share price today is $0.76 as on at the close of the market. Rani Therapeutics Holdings share today touched a day high of $0.84 and a low of $0.78.

What is the 52 week high and 52 week low for Rani Therapeutics Holdings share?

Rani Therapeutics Holdings share touched a 52 week high of $3.87 on and a 52 week low of $0.45 on . Rani Therapeutics Holdings stock price today i.e. is closed at $0.76,which is 80.47% down from its 52 week high and 69.77% up from its 52 week low.

What is Rani Therapeutics Holdings's market capitalisation today?

Rani Therapeutics Holdings market capitalisation is $0.00T as on .

How to invest in Rani Therapeutics Holdings Stock (RANI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Rani Therapeutics Holdings on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rani Therapeutics Holdings Shares that will get you 1.9841 shares as per Rani Therapeutics Holdings share price of $0.76 per share as on September 17, 2026 at 8:46 am IST.

What is the minimum amount required to buy Rani Therapeutics Holdings Stock (RANI) from India?

Indian investors can start investing in Rani Therapeutics Holdings (RANI) shares with as little as ₹95.83 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.30 in Rani Therapeutics Holdings stock (as per the Rupee-Dollar exchange rate as on ). Based on Rani Therapeutics Holdings share’s latest price of $0.76 as on September 17, 2026 at 8:46 am IST, you will get 13.2275 shares of Rani Therapeutics Holdings. Learn more about fractional shares .

What are the returns that Rani Therapeutics Holdings has given to Indian investors in the last 5 years?

Rani Therapeutics Holdings stock has given -95.97% share price returns and 29.9% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?